Atea Pharmaceuticals Inc
(AVIR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,467 | -115,909 | -81,478 | -73,412 | -42,077 |
| Depreciation Amortization | -2,983 | -5,205 | -2,309 | 50 | 7 |
| Accounts receivable | N/A | N/A | -4,514 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,851 | -1,983 | -3,416 | 9,351 | -877 |
| Other Working Capital | -3,935 | -46,586 | -50,723 | -28,402 | -28,616 |
| Other Operating Activity | 14,386 | 48,701 | 43,003 | 14,218 | 12,554 |
| Operating Cash Flow | $-29,850 | $-120,982 | $-99,437 | $-78,195 | $-59,009 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,480 | -453,467 | -486,955 | N/A | N/A |
| PPE Investments | N/A | -1,943 | -1,943 | -1,923 | -44 |
| Investing Cash Flow | $24,480 | $-455,410 | $-488,898 | $-1,923 | $-44 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 165 | 370 | 370 | 223 | 223 |
| Financing Cash Flow | $165 | $370 | $370 | $223 | $223 |
| Beginning Cash Position | 188,658 | 764,680 | 764,680 | 764,680 | 764,680 |
| End Cash Position | 183,453 | 188,658 | 176,715 | 684,785 | 705,850 |
| Net Cash Flow | $-5,205 | $-576,022 | $-587,965 | $-79,895 | $-58,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,850 | -120,982 | -99,437 | -78,195 | -59,009 |
| Capital Expenditure | N/A | -1,943 | -1,943 | -1,923 | -44 |
| Free Cash Flow | -29,850 | -122,925 | -101,380 | -80,118 | -59,053 |